Baltimore, Maryland / January 21, 2014 / In a recently released article, Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, notes in a recent article that the broad popularity and increasing sales growth of ForeverGreen Worldwide’s (OTCQB – FVRG) signature personal care product PowerStrips could prove to be a game changer for the company.
The PowerStrips line, which along with its FG Xpress segment, was pre-launched a year ago, and ForeverGreen is set to make the product widely available across the globe in 2014 to meet the pent-up demand. In anticipation of the full-scale launch, the company recently added powerful industry leaders to the executive team which not only helps validate the uniqueness of the FDA listed product, but will substantially aid in enhancing the visibility, distribution and global footprint of the product. If, as management expects, broad adoption and sales of PowerStrips occur, it could put ForeverGreen in the top tier of the direct marketing arena.
PowerStrips combine a proprietary blend of ancient herbs, minerals and elements into a patented and proprietary effortless product that is applied topically. Once applied, the technology uses muscle and tissue to activate and boost energy simultaneously in areas of pain and discomfort and at a cellular level, bringing rejuvenation to the body. With 1.5 billion people suffering from chronic pain, this product is a potential game changer as it has a Class 1 medical device listing by the FDA, which is a huge differentiator in the market as compared to other, similar products sold today.
In the article Goldman states, “Given that sales of PowerStrips alone approached $12 million in 2013 during the pre-launch phase, it is easy to see why sales are expected to escalate substantially in 2014. Moreover, since ForeverGreen management has recently provided Wall Street with monthly sales updates, investors can monitor overall progress and sales success rates, thus providing a healthy dose of comfort in the stock’s future, just like PowerStrips themselves.”
This press release contains excerpts of our most recently published sponsored article on ForeverGreen Worldwide Corporation. To view a sponsored research report, article, disclosures and disclaimers, or to download the report and articles in their entirety, please visit http://www.goldmanresearch.com/.
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and micro cap stock research reports, articles, daily stock market blogs, and popular investment newsletters. Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co
A Goldman Small Cap Research report, update, newsletter, or article is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download our research, view our disclosures, or for more information, visit http://www.goldmanresearch.com/.
About ForeverGreen Worldwide Corporation (OTCQB - FVRG): ForeverGreen Worldwide Corporation develops, manufactures and distributes an expansive line of all natural whole foods and products to North America, New Zealand, Europe, Asia, South America and Africa. Offerings include their new global offering, PowerStrips. Additionally, they offer Azul and FrequenSea™ whole-food beverages with industry exclusive Marine Phytoplankton, Versativa line of hemp-based whole-food products, A.I.M. Transfer Factor immune support, 03World™ weight management products, Pulse-8 powdered L-arginine formula, TRUessence™ Essential Oils and Apothecary, 24Karat Chocolate®, and an entire catalog of meals, snacks, household cleaners and personal care products.
For more information, visit the Company’s website: http://www.forevergreen.org/
Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100